AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2025
Jan 7, 2025
33510_dirs_2025-01-07_bfd79cd6-868c-419d-a3c6-d69118a4b0ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2025-01-06
Reporting Person: Graham Juan (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2021 | Direct |
More from Perspective Therapeutics, Inc.
Report Publication Announcement
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Report Publication Announcement
2026
May 11
Report Publication Announcement
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16